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HumanAlthough the functional role of nicotinamide nucleotide transhydrogenase (Nnt) remains to be fully
elucidated, there is strong evidence that Nnt plays a critical part in mitochondrial metabolism by maintaining
a high NADPH-dependant GSH/GSSG ratio, and thus the control of cellular oxidative stress. Using real-time
PCR, spectrophotometric and western blotting techniques, we sought to determine the presence, abundance
and activity level of Nnt in human heart tissues and to discern whether these are altered in chronic severe
heart failure. Left ventricular levels of the NNT gene and protein expression did not differ signiﬁcantly
between the non-failing donor (NF) and heart failure (HF) group. Notably, compared to NF, Nnt activity rates
in the HF group were 18% lower, which coincided with signiﬁcantly higher levels of oxidized glutathione,
lower glutathione reductase activity, lower NADPH and a lower GSH/GSSG ratio. In the failing human heart a
partial loss of Nnt activity adversely impacts NADPH-dependent enzymes and the capacity to maintain
membrane potential, thus contributing to a decline in bioenergetic capacity, redox regulation and
antioxidant defense, exacerbating oxidative damage to cellular proteins.l Children's Hospital, Flemington
fax: +61 3 93456001.
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NADPH transhydrogenase (Nnt, E.C.1.6.1.2), located within the
inner mitochondrial membrane of animal cells, has a major function
in the formation of NADPH and NAD+ from NADP+ and NADH by
translocating protons across the inner membrane from the cytosol to
the mitochondrial matrix [1]. Nnt activity is driven by the electro-
chemical proton gradient which promotes a conformational change in
Nnt from an inactive to active state with catalytic sites for both NAD
(H) and NADP(H) exposed on the matrix side of the inner membrane
(see [2–5]). Based on ﬂux studies, it has been estimated that Nnt is a
major source of NADPH, accounting for up to 45% of the total NADPH
supply, with the remainder arising from the pentose phosphate
pathway, NADP-isocitrate dehydrogenase (NADP+-ICDH) and the
mitochondrial NAD(P)-malic enzyme (ME2) [6,7].
One proposed functional role for Nnt is the redox regulation of
NADPH-dependent thiols, particularly mitochondrial glutathione,
thioredoxin, peroxiredoxins and glutaredoxin [8,9]. As the conversion
of oxidized glutathione (GSSG) to reduced glutathione (GSH) requiresNADPH, Nnt activity serves a critical task in maintaining a high GSH:
GSSG ratio, thus protecting against reactive oxygen species-related
damage and potentially limiting opening/induction of IMAC (inner
mitochondrial anion channel) [10] and potentially also the MPT
(mitochondrial permeability transition) pore [11]. Strong support for
this role of Nnt was derived from work with Nnt deletion mutants of
the nematode Caenorhabditis elegans which became highly sensitive
to oxidative stress when superoxide formation was augmented with
methylviologen, thus markedly decreasing surviving larvae that could
successfully progress to the adult stage [12]. This effect was reversed
by reintroduction of the NNT gene.
Although much of the previous work on Nnt has been performed in
non-mammals, gene quantiﬁcation using RT-PCR and northern blotting
in the mouse has conﬁrmed expression of the NNT gene in all major
organs, with the highest expression being in the heart [13]. Nnt activity
has been measured in numerous animal species, all demonstrating the
highest rates in cardiac mitochondrial fractions [14]. However, to date
Nnt activity and its gene or protein expression have not been previously
reported for the human heart. There is nowmounting evidence that the
pathogenesis and progression of human heart failure involves aug-
mented generation of reactive oxygen species and related oxidative
stress [15–19]. Thus, the aim of the present study was to determine the
expression and activity levels of Nnt in left ventricular myocardium
from end-stage heart failure patients and non-failing donors.
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2.1. Patient sample preparation
Explanted heart tissue biopsies were obtained from patients with
end-stage chronic heart failure (HF) undergoing cardiac transplantation
(NYHA Class IV, mean age of 50±3 years, left ventricular ejection
fraction of 24±2%,n=31),with approval by theAlfredHospitalHuman
EthicsCommittee forDiscardedTissueResearch. Prior to transplantation
all HF patients had a recent history of treatment with statins, diuretics,
ACE inhibitors, β-adrenoreceptor antagonists and Ca2+-antagonists.
Non-failing donor hearts (NF, mean age of 55±3 years, left ventricular
ejection fraction of 64±3%, n=20) were obtained from multi-organ
donors following subarachnoid hemorrhage-related brain death, and
although they were free of overt cardiovascular disease, their hearts
were unsuitable for transplantation for technical reasons. The use of
theseNFmyocardial biopsieswasapproved for researchbydonor family
consent and the VictorianOrganDonation Service, Australian Red Cross.
Upon dissection human left ventricular myocardium was immediately
frozen in liquid N2 and stored at−80 °C. Tissue extracts were prepared
by homogenizing frozen ground tissues in 10× volume of ice-cold
phosphate buffer, pH7.4, followedby centrifugation at 6000g for 10 min
at 4 °C. For puriﬁed mitochondrial protein, mitochondria were isolated
from 100 mg of frozen left ventricular tissues using the Qiagen
Mitochondrial Isolation kit according to the manufacturer's protocol.
Extractswere stored at−80 °C until use. Protein contentwas estimated
using the bicinchoninic acid (BCA) assay (Sigma-Aldrich).
2.2. Human NADPH transhydrogenase antibody production and Nnt
protein expression
Custom preparation of monoclonal antibodies against human Nnt
and epitopemappingwas as follows. HumanNNTdomain III cDNAwas
ampliﬁed by RT-PCR from human placenta total RNA and cloned into
pQE30 vector (Qiagen, USA) at BamHI/SalI sites. Protein expression
and puriﬁcation by metal chelate afﬁnity chromatography was
performed under denaturing conditions using standard protocols.
The protein was dialyzed against phosphate buffered saline and used
for immunization of BalB/c mice. Cell fusion, cloning and selection
were accomplished using standard hybridoma technology procedures
and enzyme-linked immunoassays. One clone, 4F6, was chosen for
further work due to its excellent ability to recognize Nnt in western
blotting. The epitope has been mapped by analyzing its reactivity
towards truncation mutants. 4F6 reacts with overlapping fragments
835–983 and 968–1043 but does not bind fragment 835–979.
Therefore, the epitope for 4F6 lies within the fragment 968-
TVNSAAQEDPNSIIAG-983 of the human enzyme. This fragment
represents “loop D” of the domain III. Also, this antibody reacts with
Nnt from other mammals (rat, mouse, pig, bovine), chicken and
xenopus, but does not react with C. elegans or Escherichia coli proteins
[12]. The sequence of the fragments is well conserved between the
species and the only two non-conserved residues, E-975 and/or I-982,
may be critically important for interaction with the antibody.
Nnt protein expression in isolated human heart mitochondria was
determined using standard western blotting conditions. 5 µg protein
per lane was run on a 10% SDS-PAGE gel and transferred to a PDVF
membrane at 100 V for 1 h. Membranes were blocked for 1 h at room
temperature with TBS-Tween (TBST) +5% skim milk (TBST/skim)
and incubated overnight with primary antibody at 4 °C. The primary
antibody mixture contained custom-made mouse monoclonal α-Nnt
(clone 4F6; 1:1000 dilution) and monoclonal α-porin (VDAC1) as a
mitochondrial reference standard (Molecular Probes, 1:2000 dilu-
tion), and was prepared in TBST/skim. Membranes were washed with
TBST and incubated with secondary Ab (goat α-mouse/HRPO
conjugate; 1:2000 dilution in TBST/skim; Biorad) for 1 h at room
temperature. Band detection was via ECL chemiluminescent reagent(Packard Biosciences). Membranes were then exposed to ﬁlm using a
Kodak X-Omat processor and bands analyzed using Visionworks
analysis software (UVP).2.3. Partial puriﬁcation of Nnt by immunocapture
Nnt was partially puriﬁed from isolated human heart mitochon-
dria using an immunocapture bead matrix (Mitosciences; Eugene,
OR). 200 μl (1 mg) of mitochondrial protein was initially solubilized
with 20 μl of 10% dodecyl-β-D-maltoside (Anatrace) for 30 min on ice,
followed by a 10-min centrifugation at 16,000g (4 °C). The solubilized
protein (200 μl supernatant) was then incubated with 10 μl of bead
matrix (cross-linked to 25 μg anti-Nnt monoclonal antibody, in 160 μl
PBS, pH 7.2) for 3 h at room temperature with continuous rotation.
Excess sample was washed three times from the beads with
100 volumes of 50 mM Tris–HCl, pH 7.4, followed by gentle
centrifugation at 1000g for 1 min. Nnt protein was eluted from the
beads by the addition of 30 μl 20 mM glycine, pH 2.5, incubation at
room temperature for 10 min, followed by 1 min of gentle centrifu-
gation at 1000g. The supernatant containing enriched Nnt was taken
from above the beads and the elution procedure repeated twice to
maximize sample recovery. 10 μl of 1.5 mM Tris, pH 8.8 was added to
the combined eluents to neutralize the samples, which were then
stored at −80 °C for further analyses.2.4. NNT gene expression
NNT gene expression was measured using real-time PCR techni-
ques. RNA was freshly extracted from frozen left ventricular tissues
using phenol/chloroform extraction (RNAwiz, Ambion) according to
the manufacturer's instructions. Total RNA was quantiﬁed using the
Nanodrop ND-1000 spectrophotometer and reverse transcribed into
cDNA using the High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems; ABI). Real-time PCR reactions were prepared
by the addition of 10 μl Taqman®Universal PCRmaster mix, 1 μl FAM-
labelled pre-designed primer/probe for human NNT (Taqman Gene
Expression Assay Id: 00202583_m1; ABI) and 9 μl cDNA (diluted 1/10
in RNAse-free H2O) in triplicate to a 384-well reaction plate (ABI).
Plates were run under standard thermal cycling conditions in an ABI
Prism 7900HT PCR machine. Ct values for Nnt were normalized to
those of human GAPDH (Assay Id; 99999905_m1), which were
measured using the identical cDNA samples in a singleplex assay on
the same plate. Primer/probe mixes were designed by Applied
Biosystems to be highly speciﬁc to the gene of interest, with primers
crossing at least two exon boundaries, preventing the reaction from
detecting genomic DNA contamination.2.5. Nnt activity
Nnt activity was measured in isolated human heart mitochondria
using a Cary 300 UV-VIS double beam spectrophotometer (Varian Inc)
in a 1-ml reaction volume, essentially as described [20]. The reaction
mixture was composed of 50 mM Tris (pH 8.0), 0.5% Brij-35, 1 mg/ml
lysolecithin, 300 µM APAD (3-acetylpyridine adenine dinucleotide;
Sigma-Aldrich), an analogue of NAD+, and 300 µM β-NADPH. APAD
was used instead of NAD+ because of the different absorption
spectrum of APADH as compared to those of NADPH and NADH.
The reaction was initiated by the addition of 50 µg mitochondrial
protein (20 µl volume) and the change in absorbance monitored at
375 nm for 3 min. Rates were converted to nmol APAD reduced/min
using the mmolar extinction coefﬁcient of 5.1 mM−1, cm−1 for APAD
and normalized to protein, which was determined using the BCA
assay.
1140 F.L. Sheeran et al. / Biochimica et Biophysica Acta 1797 (2010) 1138–11482.6. Protein carbonylation
Protein carbonylation refers to side chain proteins oxidised by
reactive oxygen species to form reactive aldehydes and ketones. These
can be reacted further with 2,4-dinitrophenylhydrazine (DNP) to
form hydrazones in which carbonyl species can be detected using
immunological blotting techniques. Direct oxidation was therefore
measured using the Oxyblot Protein Oxidation Detection Kit (Chemi-
con, USA) according to the manufacturer's protocol. Brieﬂy, carbonyl
groups were derivatized by reaction with DNP for 15 min and DNP-
derivatized proteins were then resolved by 10% SDS-polyacrylamide
gel electrophoresis and transferred to a polyvinylidene ﬂuoride
membrane. Membranes were incubated overnight with primary
antibody to the DNP moiety and then with secondary goat anti-
rabbit/horseradish peroxidase antibodies. Signals were visualized by
chemiluminescence detection using a Kodak X-Omat ﬁlm processor
and band desitometry was determined using Visionworks analysis
software (UVP, USA).2.7. Determination of GSH and GSSG
GSH and GSSG, and total glutathione (GSH+GSSG) were quantiﬁed
using the GSH/GSSG-412 assay kit (CAT: 21040; OxisResearch, USA).
Tissue extracts for GSH+GSSGwere prepared by homogenizing frozen
ground tissues in 10 volumes of ice cold phosphate buffer, followed by
centrifugation at 2000g for 10 min at 4 °C. Homogenates were stored at
−80 °C until required. For quantiﬁcation of GSSG, tissues were
processed as for total glutathione, with the addition of 3 mM of the
thiol scavenging agent, 1-methyl-2-vinylpyridinium triﬂuoromethane-
sulfonate (M2VP) to the homogenization buffer, which provides
complete derivatization of GSH within 1 min, preventing its participa-
tion in the GSH cycling assay. Samples were then assayed spectropho-
tometrically according to the kit protocol, based on themethod of Tietze
[21].2.8. Glutathione reductase activity
Glutathione reductase (GR) activity was measured in tissue
extracts based on the rate of reduction of GSSG to GSH by NADPH.
Activity was measured by the addition of 20 μl tissue extract to an
assay medium (100 mM phosphate buffer, pH 7.5; 1 mM EDTA)
containing 1 mMGSSG, 0.1 mMNADPHand 0.75 mMDTNB (1 ml ﬁnal
volume). Activity was measured by the rate of absorbance increase at
412 nm and compared to that of known standards (Sigma Aldrich).Fig. 1. Protein expression of Nnt and Porin (VDAC1) in isolated human heart
mitochondria. 5 μl mitochondrial protein from NF (n=20) and HF (n=31) hearts
(left ventricle) was run on a 10% SDS-PAGE gel, transferred to a PVDF membrane and
blotted with monoclonal antibodies to Nnt and VDAC1. (A) Nnt expression following
1 min ﬁlm exposure; (B) VDAC1 expression following 20 sec ﬁlm exposure.2.9. Determination of NADPH/NADP
Myocardial NADPH/NADPwas determined via high pressure liquid
chromatography (HPLC) using the method of Bernocchi et al. [22],
brieﬂy detailed as follows. Frozen tissues were ground in liquid N2
with 0.4 N HClO4 and centrifuged at 4000 g (4 ºC, 10 min). The pH of
the supernatant was adjusted between 6 and 6.5 with KOH, and these
samples were assayed for NAD and NADP. For NADH and NADPH,
tissues were ground in phenol buffer (0.64 M phenol, 0.07 M
phosphate buffer, pH 7.8) and added to an equal volume of chloroform
and thawed to 4 ºC in the dark. These homogenates were centrifuged
and the aqueous phase was washed ﬁve times with 5 ml diethyl ether
before extracts were used for HPLC. Samples for NADPH and NADP
assaywere run on a C18 3 μmRP column (0.46×15 cm, Supelchem) via
a mobile phase gradient of buffer A (2.5% v/v acetonitrile, 5 mM
tetrabutylammoniumand0.1 MKH2PO4, pH6.0) andbuffer B (25% v/v
acetonitrile, 5 mM tetrabutylammonium and 0.1 M KH2PO4, pH 5.5).
Extract peaks were detected at 260 nm and identiﬁed by co-elution of
known standards.3. Results
3.1. Nnt protein levels
Fig. 1A shows the detection of the human myocardial Nnt protein
at approximately 110 kDa on a 10% SDS-PAGE gel, as predicted
following cleavage of transit peptide and precursor [12]. The Nnt
bands were revealedmaximally within 2-min ﬁlm exposure using ECL
detection reagent with a 5 μg/lane mitochondrial protein loading.
Expression of VDAC1 was evident at 30 kDa and was highly abundant
(Fig. 1B).
Analysis of protein band density corresponding to Nnt indicated
that although the Nnt levels in the HF group tended to be lower, these
did not differ signiﬁcantly from NF and HF groups (p=0.248), even
when each sample was normalized to the VDAC1 level (p=0.275;
Fig. 2A). There was no signiﬁcant difference in VDAC1 expression for
these samples (Fig. 2B; p=0.829 NF vs. HF), indicating that under
identical protein loading conditions, mitochondrial content was
similar between the two groups. This was further conﬁrmed by the
presence of similar citrate synthase levels in both groups (data not
Fig. 2. Nnt protein and porin (VDAC1) in non-failing and failing human left ventricle.
(A) Nnt was detected in isolated human heart mitochondria using western blotting
techniques with monoclonal Nnt antibody. Loading: 5 μg mitochondrial protein/lane.
Values represent mean density of Nnt bands normalized to VDAC1 expression.
(B) VDAC1 was detected in isolated human heart mitochondria with monoclonal
VDAC1 antibody. Loading: 5 μg mitochondrial protein/lane. Values represent mean
density (pixels) of VDAC1 expression. All values are expressed as mean±SEM. (n=20)
vs. HF (n=31).
Fig. 3. (A) NNT gene expression in non-failing and failing left ventricle. Values represent
mean ΔCt±SEM (normalized to GAPDH). As each cycle represents a doubling in gene
product, this difference equates to a 1.2-fold decrease in expression in the heart failure
group, p=0.222, NF (n=20) vs. HF (n=31). (B) Nnt Activity in Non-failing and Failing
humanheart.Nnt activitywasmeasured spectrophotometricallyusing50 μg (20 μl) isolated
human heart mitochondria in a 1-ml reaction volume. Values represent mean±SEM,
p=0.0038, NF (n=20) vs. HF (n=31).
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ventricle, even in end-stage chronic heart failure.
3.2. NNT gene expression
For NNT gene expression the human NNT gene sequence was
accessed from the Entrez Gene (NCBI) Database (Gene ID: 23530) and
complementary FAM-labelled primer/probe reaction mixes were
manufactured to this sequence by Applied Biosystems (ABI). Primers
crossed at least two exon boundaries and therefore would not pick up
any genomic DNA contamination. RNA was isolated from frozen
ground human heart tissues and analyzed for NNT gene expression
using real-time PCR techniques. NNT gene expression was normalized
to that of GAPDH run for identical cDNA samples on the same reaction
plate.
Although NNT gene expression values in the HF group were
marginally lower than those in NF these were not signiﬁcantly
different (Fig. 3A; p=0.222). Gene expression was relatively abun-
dant, with ﬂuorescence intensity reaching the cycle threshold at an
average of 24.3 cycles for NF and 24.1 for HF tissues, compared to
17–18 cycles for GAPDH. Expression was also highly conserved
between individuals with small variation between individual values.ΔCt values normalized to GAPDH were 6.1±0.2 for NF vs. 5.8±0.1 in
HF tissues, (p=0.222). Neither GAPDH nor 18srRNA expression
differed between NF and HF (p=0.859, p=0.167, respectively).
However, heart failure severity, based on measurement of molecular
markers of heart failure, was conﬁrmed via real-time PCR. Atrial
natriuretic peptide and β-myosin heavy chain gene expression were
increased in left ventricular samples by 4-fold (p=0.009) and 1.8-fold
(p=0.003), respectively, in the heart failure group (data not shown).
These results indicate that bothNnt protein levels and gene expression
do not signiﬁcantly differ between NF and HF human heart tissues.
3.3. Cardiac Nnt activity
Although in vivo the formation of NADPH by Nnt is highly favored,
the reaction has been proposed to operate in reverse under certain
physiological conditions, e.g. ischemic stress [9]. For the assay of Nnt
activity, the reaction was performed in reverse using the analogue of
NAD+, APAD, which has a higher oxidation potential than NAD+ and a
different absorption spectrum especially for the reduced form, and is
thus useful for the measurement of activity in dehydrogenase or
transhydrogenase enzymes [23,24]. Nnt activities were estimated at
60–100 nmol/min/mg protein, which is in line with that reported for
other solubilised mitochondrial transhydrogenases [25]. Comparing
Fig. 5. Effect of palmitoyl CoA on Nnt activity. (A) 50 μg (20 μl) isolated non-failing
human heart mitochondria were incubated for 5 min prior to assay with increasing
doses of palmitoyl CoA. (B) Group average effect of palmitoyl CoA at 10, 100 and
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activity rates of 82.6±2.0 in the NF and 67.8±2.1 nmol/min/mg
protein in the HF group (p=0.0038; Fig. 3B).
To conﬁrm that this activity was speciﬁc for Nnt, isolated
mitochondria were incubated for 5 min with increasing concentra-
tions of 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD chloride) an
inhibitor of Nnt [26]. Rates following exposure to 10 μM, 100 μM and
1 mM NBD chloride were 89%, 67% and 34% of control values
respectively (n=6 per group; Fig. 4). Inhibitory effects were also
examined via incubation with palmitoyl CoA, which speciﬁcally
interferes with Nnt activity by competition with NADPH-binding
sites [27] (Fig. 5A, B).
We also sought to determinewhetherNnt activitywas inﬂuenced by
oxidative stress and antioxidant status. While post-oxidative products
peroxynitrite and 4-hydroxynonenal had no effect on Nnt activity even
at millimolar concentrations (data not shown), there was a moderate
increase in Nnt activity following exposure to hydrogen peroxide
(Fig. 6). Incubation with 10 μM, 100 μM and 500 μM H2O2 resulted in a
113%, 127% and 136% respective increase in Nnt activity compared to
controls (n=4). Thus, Nnt activity may be augmented as an important
mechanism of response to increased hydrogen peroxide, since mito-
chondria rely mainly on the production of reduced glutathione for the
removal of peroxides rather than catalase (but see Section 4). However,
extremely high, supra-pathophysiological concentrations of peroxide
above 1 mM caused a decline in Nnt activity (not shown).
To conﬁrm that antibody binding was not affected by oxidative
agents, peroxide-treated samples were run on a 10% SDS-PAGE gel
and blotted for Nnt. As shown by western blotting, antibody binding
was not prevented by NBD chloride nor H2O2 exposure, (Insets, Figs. 4
and 6). Thus, activity measured can be considered to be speciﬁc, whileFig. 4. Effect of NBD chloride on Nnt activity. 50 μg (20 μl) isolated non-failing human
heart mitochondria was incubated for 5 min with NBD chloride and Nnt activity
measured. n=6 per group. Results expressed asmean±SEM. (Inset above: Nnt protein
expression in identical mitochondrial samples treated with NBD chloride).
1000 μM, n=4 per group. Results expressed as mean±SEM.modiﬁcation of the enzyme by oxidizing agents or thiol modiﬁcation
appeared to have no effect on the binding capacity of the antibody.
Given the link between Nnt, NADPH and glutathione, we further
explored the possibility of feedback regulation of Nnt by GSH and GSSG.
However, GSH (up to 1 mM)orGSSG (up to5 mM)hadnoor little effect
(data not shown). In contrast, S-nitrosoglutathione (NO-GSH) above
1 mMinhibitedNnt signiﬁcantlywith 100% inhibitionat 3 mMorhigher
concentrations (Fig. 7). Inhibition by NO-GSH is likely mediated via
release of nitric oxide.
3.4. Oxidative modiﬁcation of Nnt
Nnt partially puriﬁed from isolated human heart mitochondria by
immunocapture was used to determine whether it represented a
signiﬁcant target of oxidative damage under both normal conditions
and thediseased state. Nnt frombothNFandHFmitochondria displayed
evidence of protein oxidation (DNP-related carbonylation) (data not
shown). These same samples were conﬁrmed to be Nnt-speciﬁc by
immuno-blots. Therewas a higher state of DNP-related carbonylation in
theHF group (DNP:Nnt density ratio 0.54 NF vs. 0.70 HF). Thus, the high
generation of DNP indicates that Nnt is a signiﬁcant target of oxidative
damage, to some extent observed even in the NF group, which is subject
to the brief, brain death-related acute oxidative stress that is induced by
the Cushing reﬂex effect.
3.5. GSH/GSSG
Samples from the heart failure group showed a signiﬁcant decrease
in total GSH (Fig. 8A), i.e. GSH+GSSG, measuring an average of 60.9±
2.7 nmol/mg protein in the NF and 54.0±1.6 nmol GSH/mg protein in
HF tissues (n=20 NF, n=29 HF; p=0.022), which corresponded to a
decrease in reduced GSH levels in the HF group (p=0.027). Concur-
rently, there was a three-fold increase in GSSG in HF tissues (34.98±
Fig. 6. Effect of hydrogen peroxide on Nnt activity. 50 μg (20 μl) isolated non-failing
human heart mitochondria was incubated for 5 min prior to assay with increasing
doses of hydrogen peroxide. n=4 per group. Results expressed as mean±SEM. (Inset
above: Nnt protein expression in identical mitochondrial samples treated with H2O2).
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protein HF, n=27; p=0.0068).
In contrast to our ﬁndings, Biagioli et al., [28] have reported GSH and
GSSG values for the donor human heart during transplantation that are
markedly lower compared to our present study [GSH (7.8±2.47 pmol/Fig. 7. Effect of S-nitrosoglutathione (NO-GSH) on Nnt activity. Isolated human heart
(left ventricle) mitochondria (50 μg protein in 20 μl) were incubated for 5 min with
NO-GSH and Nnt activity was measured spectrophotometrically. Results are expressed
as mean±SEM, n=6 per group.mg protein and GSSG (1.58±0.55 pmol/mg protein). Janssen et al [29]
in a study of failing human hearts, that were subsequently subjected to
additional experimental ischemia-reperfusion stress, reported GSSG
levels (0.61±0.12 μmol/g protein) that are generally comparable with
those of our present study however GSH values are higher (25.3±
4.5 μmol/g protein). Studies in blood from healthy individuals have
estimated GSH levels at 1.01 mmol/L [30], while in control human
skeletalmuscle biopsies, values of 1.6 nmol GSH+GSSG/mgwetweight
have been reported [31].
GSSG levels were comparable to other reported values, with the
present study values of 35–110 pmol GSSG/mg protein comparable to
200 pmol/mg protein reported in C. elegans [12]. In patients
undergoing coronary artery bypass graft (CABG) surgery, coronary
sinus bloodGSSG levels have been reported as negligible prior to aortic
cross clamping, increasing to 100–500 pmol/ml within minutes of
cross-clamp removal and returning to near zero levels within 10 min
following coronary bypass [32]. Similar results have been reported in
more recent studies of elective CABG patients [33,34]. In human
skeletal muscle biopsies, values of 60 pmol GSSG/mgwet weight have
been reported [31].
The GSH/GSSG ratio was lower in the failing left ventricular tissues,
with a ratio of 2148±591 in NF (n=20) and 892±169 in HF (n=29),
p=0.049, Fig. 8B. Our GSH/GSSG ratios were markedly higher than the
ratio of 60 reported for the nematode C. elegans [12] and 150 reported
for the transgenic glutaredoxin-2-overexpressing mouse heart [35]
although a ratio of 441 was reported in Rhodobacter sphaeroides [36].
The highGSH/GSSG ratio ismainly attributed to both the highGSH level
aswell as the lowGSSG values in the humanmyocardial tissues, being in
the pmol/mg protein range. A predicted GSH/GSSG range of 30 to 300
has been quoted by Aon et al. [37] in their study of isolated guinea pig
cardiomyocytes. They found that reversible membrane depolarization
occurred when the GSH/GSSG ratio was clamped at ratios between 150
and 100, however when the ratio was clamped below 50 the myocytes
progressed to irreversible depolarization, maximal production of
reactive oxygen species (ROS) and loss of matrix contents [37]. These
results suggest that a higher (N150), rather than lower (b100) GSH/
GSSG ratio is preferable in these cardiomyocytes.
3.6. Glutathione reductase activity
The activity of glutathione reductase, which reduces GSH from
GSSG, was signiﬁcantly higher in the NF, (9.6±0.26 mU/min/mg
protein) compared to HF (8.7±0.16 mU/min/mg protein, p=0.0028,
Fig. 9A).
3.7. NADPH/NADP
Compared to NF, NADPH (NF: 795±81 vs. HF: 298±29 nmol/mg
protein, p=0.00013) and NADP (NF: 318±34 vs. HF: 226±26 nmol/
mgprotein,p=0.0475) levelsweremarkedly lower in theHFgroupwith
a corresponding lower NADPH/NADP ratio (Fig. 9B).
4. Discussion
In this study it was demonstrated for the ﬁrst time that, despite
relatively normal expression of Nnt and comparable Nnt protein levels
between the NF and HF groups, there is a signiﬁcant decrease in Nnt
activity in the failing human heart. As we have detected DNP-related
carbonylation of Nnt isolated by monoclonal Nnt-immunocapture
technique it is likely that Nnt activity may be impeded by post-
oxidative protein modiﬁcation. However, it is important to note that
our determination of decreased Nnt activity is the maximal activity of
the reverse reaction, thus it is possible that the forward-reaction
driven Nnt activity may be even lower. As the rate of these Nnt
reactions are dependent on mitochondrial membrane potential and
this is decreased in HF [15,38], then the Δp-driven forward reaction
Fig. 8. (A) Total, reduced and oxidized glutathione in non-failing and failing human
heart. Left ventricular tissue extracts were analyzed spectrophotometrically using the
GSH-GSSG-412 assay kit. Values represent mean±SEM. p-Values NF vs. HF: Total GSH
(GSH+GSSG): p=0.029, GSH: p=0.027, GSSG: p=0.0068. (B) GSH/GSSG ratio in
human non-failing and failing heart. The GSH/GSSG ratio was determined by dividing
GSH (nmol/mg protein) by 2GSSG (nmol/mg protein) for each LV sample. Values
represent mean±SEM, (n=20) vs. HF (n=31).
Fig. 9. (A) Glutathione reductase activity and (B) NADPH/NADP+ ratio in human non-
failing and failing left ventricle. Values representmean±SEM.NF (n=20) vs. HF (n=31).
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activity has signiﬁcant implications relating to the reduced tolerance
of the failing heart to minimize oxidative damage to proteins and
lipids.
Although the role of Nnt and its contribution to the overall
bioenergetics of the mitochondrion is yet to be fully deﬁned, there is
substantial evidence for a number of roles of Nnt, which include:
1) Control of ROS and cellular redox state by replenishment of
antioxidant systems, namelyGSHandmitochondrial repair enzymes
(thioredoxin, glutaredoxin, peroxiredoxins andphospholipid hydro-
peroxidase), directly or indirectly using NADPH as an electron donor
[7,12,36].2) Maintenance of mitochondrial membrane potential through gener-
ation of a proton gradient by reverse reaction under conditions of
transient ischemia [9].
3) Fine regulation of Krebs cycle ﬂux by interaction with the NADP+-
ICDH [39]. There is also increasing evidence that Nnt, by regulating
the level of NADPH, is also involved in calcium homeostasis and
apoptosis, possibly through the bcl-2 and mitochondrial pore
proteins [40,41].
4.1. Implications of reduced Nnt activity on tissue glutathione levels
Glutathione is synthesized in the cytoplasm but can be exchanged
with other cellular compartments. While mitochondria are not able to
synthesize GSH, they are able to accumulate it up to a percentage of
10–25% of total cellular GSH [42,43]. Cytosolic and mitochondrial GSH
pools are distinct, although there may be an “overﬂow” or exchange
mechanism between the two compartments. The cell possesses a
number of powerful antioxidant defenses capable of counteracting
ROS and repair of oxidized molecules. These mechanisms work to
maintain cellular components in a predominantly reduced redox state
and are maintained by two major factors: (1) the reduction potential
of the electron carriers (NADH/NAD+ and FADH2/FAD) and (2) the
reducing capacity of linked redox couples present in the cytoplasm or
in the intra-organellar compartments (e.g. mitochondrial matrix) of
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glutathione (GSH/GSSG), thioredoxin (Trx(SH)2/TrxSS), glutare-
doxin, peroxiredoxins (Prx3 and Prx5) and NADPH/NADP+, of
which the latter provides the driving force for the glutathione and
thioredoxin systems. The GSH/GSSG pool is the largest of the cell and
is considered to be a major indicator of cellular redox status [44,45].
Superoxide formed by the mitochondrial respiratory chain is
removed by the action of superoxide dismutases (SOD), resulting in
the formation of H2O2. In the cytoplasm, H2O2 is further converted to
water and oxygen by the catalase enzyme. Mitochondria, however,
instead relymainly onGSH for the removal of H2O2,with the reduction
of GSH fuelled by the NADPH-producing enzymes, even though
mitochondrial catalase has been proposed to play a role [46]. Notably,
incubation with pathophysiological concentrations of H2O2 increased
Nnt activity, rather than decreased it, possibly due to an increased
demand for GSH (Fig. 6). Being a relatively unreactive ROS, H2O2 may
work as a signaling substance. GSH can also act as a potent antioxidant
in its own right, providing defense against mitochondrial-produced
ROS. GSSG is then reduced back by the action of GR whose activity is
regulated by cellular GSSG levels and which requires NADPH as an
electron donor [47]. A signiﬁcant contribution of mitochondrial
NADPH required for this reaction is supplied by Nnt, with contribu-
tions also from the NADP+-ICDH and ME2 [7,48,49]. Thus, mitochon-
drial Nnt,which is interlinkedwith the reduction of GSHbyproduction
of NADPH, is of fundamental importance in the control of ROS.
Nnt knockoutmutants of C. elegans displayed a signiﬁcant decline in
the GSH/GSSG ratio and increased sensitivity to oxidative insult
(Paraquat), determined by a dramatic decline in those progressing to
the adult stage [12]. The implications of GSH deﬁciency on mitochon-
drial function have been demonstrated in rats injected with buthionine
sulfoximine, a selective inhibitor of γ-glutamylcysteine synthetase,
which results in a signiﬁcant loss of glutathione, in which those treated
with the drug displayed grossly swollen brain mitochondria which
lacked innermembrane structural features [50]. Based on theﬁndings in
the Nnt knockout nematodes, it would be predicted that an 18%
reduction in Nnt enzyme activity in the failing human heart would have
an impact on tissue GSH levels, which was indeed seen as a moderate
(11%) decrease in total glutathione (Fig. 8) in the failing heart tissue.
Given that GSSG levels in the myocardial tissues were very low (pmol/
mg protein amounts vs. nmol GSH+GSSG/mg protein) it can be
assumed that almost all of the total GSH pool was in the reduced form,
translating to lower reduced GSH levels in the failing heart tissues.
Assuming that the 11% fall in total GSH levels was consistent across all
cellular compartments, and given that mitochondrial GSH accounts for
10–25% of the cellular total [43], this would translate to an effective loss
of a signiﬁcant part of the total mitochondrial GSH pool.
There are relatively few in depth studies examining myocardial
tissue levels of GSSG and GSH in humans that are generally free of
disease or intervention-dependent ischemia-reperfusion. However it is
likely that thedifferences inmyocardialGSHandGSSG levels reported in
the present study, compared to other human studies which are also
variable,may relate to a combination of differences in handling of tissue,
assay methodology and disease state (varying severity of heart failure
and donor heartswith subtle but variable ischemic injury).Most studies
referencing values for glutathione (such as [29,32,51,52]), have utilized
the enzymatic method of Tietze [21], as we have. These studies though
have used the older generation agent, N-ethylmaleimide, to derivatise
GSH so that it does not participate in the GSH cycling assay. However
this agent has limitations in terms of inhibitory action on glutathione
reductase, time required for derivatisation and capacity to permit
complete conversion of GSH. In contrast, as ﬁrst introduced by Grifﬁth
[53], we used the thiol scavenger 1-methyl-2-vinylpyridine (M2VP)
whichprovides rapid and complete removal of GSH (within aminute vs.
N1 h) but without inhibition of glutathione reductase. In a study of
mitochondria isolated from pulmonary artery epithelial cells (and not
myocardium) GSH/GSSG ratios up to 250 were measured using M2VPand were in keepingwith higher ratio values also reported by Aon et al.
[37]. It is thereforepossible that inolder studies usingN-ethylmaleimide
in the cycling assay, the level of GSSG may have been overestimated.
This methodology withM2VPmay possibly result in consistently lower
human myocardial GSSG values thus inﬂuencing a higher GSH/GSSG
ratio, however whether this permits a more accurate measure of GSSG
requires a validation study with HPLC assay methodology.
Other factors found in our studywhichwould also affect the decline
in the reduced GSH pool in the failing tissues include lower NADH and
the NADH/NAD ratio, aswell as reduced activities of NADP+-ICDH and
ME2 (not shown). Most notably, we measured NADPH levels and the
NADPH/NADP to be markedly lower in HF compared to the NF group,
which supports our ﬁndings of the concomitantly lower level of Nnt
activity, GR activity and GSH. Aon and colleagues [37] have also shown
a direct relationship betweenmitochondrial redox potential (mV) and
GSH and NADPH levels. Given that state III respiration and the
activities of several OXPHOS proteins are markedly impaired in the
failing heart [54–57], it is likely that mitochondrial membrane
potential is also affected, inﬂuencing the rate of GSH and NADPH
reduction. This, together with an increased demand on NADPH supply
due to augmented oxidative stress and NADPH oxidase activity in the
failing human heart [58], means that NADPH availability for GSH
reduction is markedly impaired.
There are a number of implications of decreased NADPH and GSH
availability in terms of antioxidant defense in the failing heart tissues.
Reduced NADPH formation by the Nnt and other NADPH-linked
enzymes would also have a direct impact on repair of oxidatively
damaged proteins and lipids, namely through the action of repair
enzymes such as glutathione peroxidase, mitochondrial thioredoxin,
glutaredoxin, peroxiredoxins and phospholipid hydroperoxidases.
Given the increased levels of mitochondrial-released superoxide [59]
and myocardial release of oxidative intermediates in the failing heart
[60–62], it is therefore likely that NADPH-linked repair mechanisms
supported by Nnt are diminished, leading to increased oxidative
damage to proteins and lipids in the failing humanheart. In isolated rat
cardiomyocytes, inhibition of glucose-6-phosphate dehydrogenase by
dehydroepiandrosterone (DHEA) led to a marked reduction in the
GSH/GSSG ratio, resulting in contractile dysfunction due to disrupted
calcium handling [63].
GSH, in particular, is a major indicator of cellular redox status, with
the GSH/GSSG ratio inﬂuencing a number of critical mitochondrial ion
channels including the IMAC and theMPT pore. TheMPT pore is amajor
player in initiatingbothapoptotic andnecrotic cell death,withoxidation
of GSH and other critical thiols favouring pore opening [64–66]. It has
been previously found in isolated rat cardiomyocytes that substrate
deprivation or localized ROS generation triggered collapse ofmitochon-
drial membrane potential (Δψm) in parallel with cyclical GSH oxidation
[67,68]. The same authors went on to further demonstrate (see also
Section 4.2 below) that decreasing the GSH/GSSG ratio to below 50
resulted in irreversible depolarization of the mitochondrial membrane,
maximal rates of oxygen consumption, together with sequential
opening of IMAC and the MPT pore leading to release of mitochondrial
matrix contents and initiation of the apoptotic cascade [37].
4.2. Oxidative modiﬁcation of Nnt and mitochondrial proteins
Increased superoxide production and markers of lipid peroxidation
have been reported in the failing human heart [60,61,69–71]. ROS
released from the mitochondrial respiratory chain may oxidatively
modify membrane-bound proteins and lipids, resulting in enzyme
dysfunction, thereby transiently contributing to the mitochondrial
membrane potential. Nnt has been shown to support protection against
singlet oxygen [72]. Previous in vitro studies using bovine heart
submitochondrial particles have demonstrated that Nnt is susceptible
to oxidative damage by Fe-ascorbate and peroxynitrate through two
separate mechanisms, with increases in endogenous ubiquinone
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oxidation of Nnt evenunder basal conditions, and a slight increase in the
proportion of oxidatively-modiﬁedNnt in the heart failure group,with a
ratio of 0.54 in the non-failing and 0.70 in the failing group (n=3 per
group), although this was not signiﬁcant due to the low sample
numbers. However, it can be concluded that Nnt represents a signiﬁcant
target of ROS-induced damage, which may lead to a decline in enzyme
function and further exacerbate a loss of GSH and the capacity to handle
oxidative stress.
4.3. Interaction between Nnt and mitochondrial membrane potential
(Δψm).
Of the NADPH-producing enzymes, Nnt is unique in that it is the
only enzyme which couples production of NADPH to the rate of
aerobic respiration, and hence the production of ROS. Early studies
of the structure and function of Nnt revealed that the reaction is
energy-dependent, with Nnt activity being driven either directly by
respiration or ATP hydrolysis through a reversal of the reaction
sequences involved in the respiratory chain-linked synthesis of ATP
[1,74]. In fact, unlike NADP+-ICDH and ME2, Nnt is the only NADPH-
generating enzyme that is linked to mitochondrial membrane
potential. The electrochemical proton gradient (Δp) generated by
respiration stimulates the Nnt forward reaction and thus, the rate of
reduction of NADP+ (≈10-fold) is also linked to an inhibition of the
reverse reaction [75,76]. This linkage to Δp makes Nnt a more
efﬁcient generator of NADPH than other NADP-linked enzymes.
These ﬁndings appear to relate to a conformational change in the
enzyme from the inactive to active state under conditions where a
proton gradient exists [75–78]. As the catalytic site for both
substrates (one each for NAD(H) and NADP(H) ) are exposed on
the matrix side of the inner membrane, the enzyme can, in principle,
either consume Δp generated by the respiratory chain in the forward
reaction or generate Δp in the reverse reaction in the absence of
other sources of Δp [9,39]. This led to the proposal by Hoek and
Rydström [9] that under conditions of transient ischemia, Nnt may
act in the reverse direction, thereby maintaining the mitochondrial
membrane potential.
The relationship between the GSH/GSSG ratio, the NAD(P)(H)/
NAD(P) redox state and mitochondrial membrane potential (Δψm)
was comprehensively studied in a series of experiments by Aon et al
[37] on isolated guinea pig cardiomyocytes. In these experiments,
the (external) GSH/GSSG ratio was clamped at ratios ranging from
300:1 to 20:1. At ratios of 150:1 to 100:1, reversible membrane
depolarization occurred in saponin-permeabilized TMRM-loaded
cardiomyocytes, with matrix components retained. At ratios of
50:1 however, irreversible membrane depolarization occurred
resulting from opening of the mitochondrial ion channel IMAC, and
later, by an unknown mechanism, a more dramatic and irreversible
opening of the MPT pore, which also induced maximal rates of ROS
production, NAD(P)H oxidation and loss of matrix constituents.
Further probing of the relationship between GSH redox status and
membrane polarization revealed that it was not the GSH/GSSG ratio
per se which inﬂuenced membrane depolarization, but rather the
concentration of GSSG. Maintaining GSSG at very low levels (10 μM)
and altering the GSH/GSSG ratio by increasing the GSH concentra-
tion, mitochondria were able to resist membrane depolarization by a
GSH/GSSG ratio as low as 20:1. Higher GSSG levels in failing
myocardium, as shown in Fig. 8, may therefore lower the threshold
for initiation of IMAC and membrane depolarization leading to
cardiomyocyte death. Notably, inhibition of Nnt with NBD chloride
resulted in irreversible membrane depolarization at ratios of 150:1
(1 μM NBD chloride) and 200:1 (10 μM NBD chloride), compared to
the control value of 50:1, highlighting the critical role Nnt plays in
maintaining the NADPH pool and a high GSH/GSSG ratio [37]. Given
that Nnt is estimated to account for at least 45% of NADPH supply[6,7], a reduction in activity could have considerable consequences
on the cellular GSH pool, increasing susceptibility to ROS-induced
cell death.
In this context it should be stressed that it has been known for a
long time that Nnt is rapidly saturated with Δp, and that the ﬁnal
extent of reduction of NADPH represents a steady-state rather than an
equilibrium [75]. This represents only one aspect of the full
complexity of the cellular systems for mitochondrial NADPH gener-
ation and utilization and their regulation. It may therefore be
concluded that the overall regulation of the redox state of mitochon-
drial glutathione by Δp is complex and indirect, but where Nnt plays a
key role.
4.4. Relationship between Nnt and NADP-linked Krebs cycle enzymes
While the precise interaction between Nnt and other NADPH-
producing enzymes remains to be fully deﬁned, several links
between Nnt and NADP+-ICDH have been identiﬁed. The interaction
between these two was initially proposed by Sazanov and Jackson
[39], who hypothesized that when excess NADPH by Nnt was
present, the NADP+-ICDH reaction could operate in reverse,
effectively providing a ﬁne regulation of Krebs cycle ﬂux in response
to changes in energy demand. Notably, this control also limits
cellular oxidative damage [79]. In mutants of E. coli lacking the
membrane-bound Nnt, growth on glucose medium was at a
signiﬁcantly reduced rate compared to wild-types but still possible
[6], indicating that absence of Nnt was not critically lethal for growth
if NADPH could be supplied by other enzymes, namely ICDH. Indeed
in E. coli transhydrogenase mutants grown on acetate, growth rate
was signiﬁcantly impaired in the absence of NADP+-ICDH [80]. In
isolated mitochondria from rat forebrain, uncoupling by CCCP
(carbonyl cyanide m-chlorophenylhydrazone) inhibited Nnt activity
through the dissipation of the mitochondrial membrane potential.
However, in these mitochondria, GSSG reduction was still evident
when isocitrate or malate were used as substrates [37], thus NADPH
production may have continued via NADP+-ICDH or ME2. Detailed
studies of NADP+-ICDH and ME2 activities in chronic human heart
failure are currently in progress in our laboratory.
4.5. Conclusions
Recent studies have identiﬁed a profound effect of Nnt dysfunction
on the perturbation of glucose and insulin homeostasis in β-cells [81].
Wehypothesize thatNntwouldhave amajor role inmyocardiumwhich
is densewithmitochondria, has a highoxygenandbioenergetic demand
and a critical requirement to manage high rates of oxidative
metabolism. This is the ﬁrst study to report NNT gene expression and
protein levels in human non-failing donor hearts and chronic end-stage
failing human hearts. Of particular note is the ﬁnding of a marked
reduction in Nnt activity in severe heart failure. Nnt represents a
signiﬁcant target of oxidative damage, which may contribute to a
decline in activity and subsequent glutathione depletion, further
exacerbating oxidative damage to mitochondrial proteins and dimin-
ishing the capacity of themyocardium to defend itself against oxidative
insult.
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